Early high antibody titre convalescent plasma for hospitalised COVID-19 patients: DAWn-plasma Source: Eur Respir J, 59 (2) 2101724; 10.1183/13993003.01724-2021 Year: 2022
Circulating fetuin-A as a biomarker predicting mortality in ICU septic patients Source: International Congress 2017 – Sepsis, infections, ARDS and beyond Year: 2017
Admission glucose concentrations independently predict early mortality in patients with community-acquired pneumonia Source: Eur Respir J 2007; 30: Suppl. 51, 482s Year: 2007
Admission serum glucose levels are a risk factor predicting short- and long-term mortality in community acquired pneumonia Source: Annual Congress 2012 - Hot topics in respiratory infections Year: 2012
On improving assessment of in-hospital mortality and ICU admisison in community-acquired pneumonia patients by using the e-CURB Source: Annual Congress 2012 - Respiratory infections: prognosis and outcome Year: 2012
IgG3 subclass deficiency as a predictive marker of mortality in patients admitted to ICU Source: International Congress 2018 – Predicting the future: biomarkers of respiratory infection Year: 2018
Early rehabilitation is associated with reduced in-hospital mortality from sepsis in patients with sarcopenia Source: International Congress 2019 – ECMO, ECCO2R and other rescue therapies in acute respiratory failure Year: 2019
Serum Albumin-Globulin ratio reversal predicts morbidity in patients hospitalized for Influenza A(H1N1) infection. Source: International Congress 2018 – Predicting the future: biomarkers of respiratory infection Year: 2018
Comparison of prospective scores for predicting mortality and hospital admission in hospitalised patients and out-patients with CAP Source: Annual Congress 2005 - Community-acquired pneumonia: clinical approaches Year: 2005
Resistin may predict severity and mortality in critically ill septic patients Source: International Congress 2018 – Critically ill patients: prognostic factors and biomarkers Year: 2018
Does the serum C-reactive protein (CRP) predict adverse outcomes in patients admitted with community acquired pneumonia? Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia Year: 2011
30-days mortality in patients admitted with COPD Source: Annual Congress 2012 - COPD exacerbation Year: 2012
Do admission glucose levels aid in predicting mortality associated with community-acquired pneumonia? Source: Eur Respir J, 50 (4) 1700307; 10.1183/13993003.00307-2017 Year: 2017
Predictors of 30-day mortality in elderly patients with community acquired pneumonia Source: International Congress 2015 – CAP: prognostic factors in frail patients Year: 2015
C-reactive protein as a predictor of mortality in patients with severe sepsis in intensive care unit Source: Annual Congress 2011 - Mechanical ventilation and lung injury: new advances Year: 2011
Low vitamin D levels at ICU admission in initially non-septic patients and outcomes Source: International Congress 2017 – Sepsis, infections, ARDS and beyond Year: 2017
Risk factors of ICU admission and death among hospitalized patients with Influenza(H1N1) Source: Annual Congress 2010 - Influenza A (H1N1): characteristics, risk factors and prognosis Year: 2010
Assessment of prognostic scores for 30-day mortality prediction in hospitalised patients with health care associated pneumonia (HCAP) Source: Annual Congress 2010 - The prognosis of community-acquired pneumonia: old and new markers of severity Year: 2010
Predictors of in-hospital mortality following in-hospital diagnosis of tuberculosis Source: Eur Respir J 2006; 28: Suppl. 50, 128s Year: 2006
Factors associated with one-year mortality in hospitalized patients with exacerbation of bronchiectasis. Source: Virtual Congress 2020 – New investigations of bronchiectasis and non-tuberculous mycobacteria Year: 2020